Monoclonal antibodies in neurology: current state and future development
Monoclonal antibodies are one of the most fastly developing areas of specific therapy for cancer, infectious, autoimmune and demyelinating diseases. The main targets of monoclonal antibodies in autoimmune and demyelinating diseases are T and B-lymphocytes, cytokines, complement, and adhesion molecul...
Main Author: | Maria N. Zakharova |
---|---|
Format: | Article |
Language: | English |
Published: |
Research Center of Neurology
2018-12-01
|
Series: | Анналы клинической и экспериментальной неврологии |
Subjects: | |
Online Access: | https://annaly-nevrologii.com/journal/pathID/article/viewFile/568/458 |
Similar Items
-
Monoclonal Antibodies as Neurological Therapeutics
by: Panagiotis Gklinos, et al.
Published: (2021-01-01) -
MRI features of myelin oligodendrocyte glycoprotein antibody disease: a descriptive study—how it differs from neuromyelitis optica spectrum disorders and multiple sclerosis
by: J. Tom Mishael, et al.
Published: (2023-07-01) -
Race for the Cure: From the Oldest to the Newest Monoclonal Antibodies for Multiple Myeloma Treatment
by: Gianfranco Lapietra, et al.
Published: (2022-08-01) -
Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience
by: Mohammad Hossein Harirchian, et al.
Published: (2015-02-01) -
Multiple Sclerosis: Current Knowledge of the Pathology and Use of Monoclonal Antibodies as a Promising Therapy
by: Josué Castellón-Arias, et al.
Published: (2023-11-01)